Morning Briefing
Summaries of health policy coverage from major news organizations
University Of California Faces Uphill Fight In CRISPR Patent Challenge
Stat: CRISPR Hearing Puts University Of California On The Defensive
If the number and tenor of questions addressed to each side during oral arguments in the CRISPR patent fight is any indication of what the patent judges are thinking, the University of California has a steep hill to climb if it wants to overturn the 2014 decision awarding key CRISPR patents to the Broad Institute of MIT and Harvard and win them for itself. A 45-minute hearing on Tuesday morning before a three-judge panel of the Patent Trial and Appeal Board, the arm of the US Patent and Trademark Office that hears challenges to patent decisions, offered the only oral arguments in the bitter fight over whether UC or the Broad deserves key patents on the CRISPR-Cas9 genome-editing technology. (Begley, 12/6)
